\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ focal\\ deficit\ \(2\)\
\-\ negative\\ toxocology\\ screen\\.\ \(0\)\
\-\ surgical\\ removal\\.\\ \\ no\\ chemotherapy\\ or\\ radiation\\.\ \(0\)\
\-\ well\\ defined\\ mass\\ in\\ the\\ left\\ cerebellar\\ tonsil\\ mass\\ with\\ fluid\\ and\\ a\\ 1\\ cm\\ enhancing\\ nodule\\.\\ no\\ significant\\ mass\\ effect\\ or\\ edema\\.\ \(0\)\
\-\ rosette\\ forming\\ papillary\\ glioneuronal\\ tumor\ \(0\)\
\-\ \\â\\€\\¢\\ hemangioblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ astrocytoma\\ \\(pilocytic\\)\ \(0\)\
\-\ \\â\\€\\¢\\ ganglioglioma\ \(1\)\
\-\ \\â\\€\\¢\\ hematoma\ \(2\)\
\-\ \\â\\€\\¢\\ metastasis\ \(6\)\
\-\ 19\\ year\\ old\\ man\\ presents\\ to\\ er\\ with\\ first\\ time\\ syncopal\\ episode\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ toxocology\\:\\ 0\\.28101262532244337\ \(0\)\
\-\ rosette\\:\\ 0\\.25278695147793373\ \(0\)\
\-\ glioneuronal\\:\\ 0\\.23830882932374392\ \(0\)\
\-\ syncopal\\:\\ 0\\.23143505347858398\ \(0\)\
\-\ tonsil\\:\\ 0\\.22335311190730203\ \(0\)\
\-\ forming\\:\\ 0\\.2020012139079523\ \(0\)\
\-\ mass\\:\\ 0\\.2013596794257542\ \(0\)\
\-\ ganglioglioma\\:\\ 0\\.1844259918429751\ \(0\)\
\-\ screen\\:\\ 0\\.1812474760110912\ \(0\)\
\-\ hemangioblastoma\\:\\ 0\\.17573202462921536\ \(0\)\
\-\ no\\:\\ 0\\.17142526902873345\ \(0\)\
\-\ pilocytic\\:\\ 0\\.1685567363211778\ \(0\)\
\-\ deficit\\:\\ 0\\.16624533164184105\ \(0\)\
\-\ papillary\\:\\ 0\\.16375113818219916\ \(0\)\
\-\ episode\\:\\ 0\\.16081517696853936\ \(0\)\
\-\ cerebellar\\:\\ 0\\.1437996757632279\ \(0\)\
\-\ 19\\:\\ 0\\.13915368563602507\ \(0\)\
\-\ nodule\\:\\ 0\\.13869505268730328\ \(0\)\
\-\ removal\\:\\ 0\\.13431729861156746\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.13265179693162324\ \(0\)\
\-\ er\\:\\ 0\\.13142924452631521\ \(0\)\
\-\ metastasis\\:\\ 0\\.1287889015361381\ \(0\)\
\-\ defined\\:\\ 0\\.12535688648940094\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.12477197757418075\ \(0\)\
\-\ effect\\:\\ 0\\.12326443382832131\ \(0\)\
\-\ hematoma\\:\\ 0\\.12298980249346121\ \(0\)\
\-\ or\\:\\ 0\\.12225888757117058\ \(0\)\
\-\ first\\:\\ 0\\.11858168441590047\ \(0\)\
\-\ radiation\\:\\ 0\\.11644587928989565\ \(0\)\
\-\ enhancing\\:\\ 0\\.11007734652696548\ \(0\)\
\-\ negative\\:\\ 0\\.10878631167413153\ \(0\)\
\-\ focal\\:\\ 0\\.10510704765101483\ \(0\)\
\-\ edema\\:\\ 0\\.10480255478600618\ \(0\)\
\-\ time\\:\\ 0\\.10415296768907309\ \(0\)\
\-\ fluid\\:\\ 0\\.10145616781737497\ \(0\)\
\-\ significant\\:\\ 0\\.10145616781737497\ \(0\)\
\-\ cm\\:\\ 0\\.10091730374350798\ \(0\)\
\-\ man\\:\\ 0\\.09302771778522634\ \(0\)\
\-\ tumor\\:\\ 0\\.09191113079639397\ \(0\)\
\-\ surgical\\:\\ 0\\.08540507179837167\ \(0\)\
\-\ well\\:\\ 0\\.0850839122183284\ \(0\)\
\-\ presents\\:\\ 0\\.0845298160586292\ \(0\)\
\-\ with\\:\\ 0\\.06881587815526011\ \(0\)\
\-\ left\\:\\ 0\\.059941517246799685\ \(0\)\
\-\ year\\:\\ 0\\.054153076484960996\ \(0\)\
\-\ old\\:\\ 0\\.05200569897818825\ \(0\)\
\-\ to\\:\\ 0\\.043929356403124245\ \(0\)\
\-\ in\\:\\ 0\\.043713136201888894\ \(0\)\
\-\ and\\:\\ 0\\.03631013999839374\ \(0\)\
\-\ the\\:\\ 0\\.03506226896384974\ \(0\)\
